Klcm Advisors, Inc. Abbott Laboratories Transaction History
Klcm Advisors, Inc.
- $840 Million
- Q4 2024
A detailed history of Klcm Advisors, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Klcm Advisors, Inc. holds 10,378 shares of ABT stock, worth $1.37 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
10,378
Previous 10,258
1.17%
Holding current value
$1.37 Million
Previous $1.17 Million
0.34%
% of portfolio
0.14%
Previous 0.14%
Shares
31 transactions
Others Institutions Holding ABT
# of Institutions
3,238Shares Held
1.31BCall Options Held
8.71MPut Options Held
8.03M-
Vanguard Group Inc Valley Forge, PA168MShares$22.2 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.3 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$10.1 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$8.68 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$7.04 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $231B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...